MedWatch

Ambu plagued by transportation troubles in disappointing year – CEO has a card up his sleeve

Two downgrades with a prospect of increased costs on freights and raw materials do not evoke optimism with Ambu's CEO Juan Jose Gonzalez when it comes to next year's financial guidance. The added expenses will impact Ambu's revenue, but the CEO still have moves ...

Photo: Ambu / PR

Ambu has been left with a bill of DKK 70m (USD 10.9m) for increased transportation costs over the past year, and with two downgrades during this period, CEO Juan Jose Gonzalez would prefer to avoid a similar situation for the new financial year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs